Sofinnova Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
43
- Investments
-
450
- Portfolio
-
98
- Exits
-
153
Sofinnova Partners General Information
Company Description
Founded in 1972, Sofinnova Partners is a venture capital firm based in Paris, France. The firm prefers to invest in companies operating in the life sciences sector and primarily focuses on investing in the healthcare and sustainability sectors.
Business Details
Website
www.sofinnovapartners.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 7-11 Boulevard Haussmann
- 75009 Paris
- France
Sofinnova Partners Investments (450)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Micropep | 26-Sep-2024 | Later Stage VC | Agricultural Chemicals | Startup | ||
Genespire | 25-Sep-2024 | Drug Discovery | Generating Revenue | |||
F2G | 12-Sep-2024 | Drug Discovery | Generating Revenue | |||
Novameat | 12-Sep-2024 | Food Products | Generating Revenue | |||
Arzeda | 25-Jul-2024 | Other Pharmaceuticals and Biotechnology | Generating Revenue | |||
deepc | 25-Jul-2024 | Decision/Risk Analysis | Generating Revenue | |||
Asceneuron | 16-Jul-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
Endoron Medical | 09-Jul-2024 | Therapeutic Devices | Clinical Trials - Phase 1 | |||
Myricx Bio | 08-Jul-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
May Health | 13-May-2024 | Later Stage VC | Surgical Devices | Generating Revenue |
Sofinnova Partners Exits (153)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Calliditas Therapeutics | 30-Aug-2024 | Merger/Acquisition | |
Amolyt Pharma | 15-Jul-2024 | ||
Pixium Vision | 31-Jan-2024 | ||
LimFlow | 15-Nov-2023 | ||
Crocus Technology | 31-Oct-2023 | ||
EryDel | 20-Oct-2023 | ||
ASSIA | 28-Dec-2022 | ||
CinCor Pharma | 12-Aug-2022 | ||
CinCor Pharma | 07-Jan-2022 | IPO | |
EnobraQ | 07-Dec-2021 | Bankruptcy: Liquidation |
Sofinnova Partners Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
Sofinnova Partners Investments by Industry, Year, and Region
Sofinnova Partners Management, Team & Partners (80)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Christophe Blanche | Chief Financial Officer | Paris, France | |||
Mats Eklund | Chief Operating Officer & Partner | Paris, France | |||
Antoine Papiernik | Managing Partner & Chairman | Paris, France | |||
Graziano Seghezzi | Managing Partner | Paris, France | |||
Henrijette Richter Ph.D | Managing Partner | Paris, France |
Sofinnova Partners Co-Investors (350)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Bpifrance | 14 | ||||
Novo Holdings | |||||
LSP Management Group | |||||
M Ventures | |||||
Roche Venture Fund |
Sofinnova Partners FAQs
-
What is Sofinnova Partners?
Founded in 1972, Sofinnova Partners is a venture capital firm based in Paris, France.
-
When was Sofinnova Partners founded?
Sofinnova Partners was founded in 1972.
-
Where is Sofinnova Partners headquartered?
Sofinnova Partners is headquartered in Paris, France.
-
What is Sofinnova Partners's total asset value?
Sofinnova Partners has around
in total assets under management. -
How many investments has Sofinnova Partners made?
Sofinnova Partners has made 450 investments.
-
What has Sofinnova Partners invested in?
Sofinnova Partners has made numerous investments in companies like Micropep, Genespire, and F2G within the Agricultural Chemicals and Drug Discovery industries.
-
What has Sofinnova Partners invested in recently?
Sofinnova Partners's latest investment was on 26-Sep-2024 in Micropep, a company within the Agricultural Chemicals industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »